Fedenia Advisers »

Abcellera Biologics shares owned by Fedenia Advisers

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Fedenia Advisers from 13F filings

Historical chart of Fedenia Advisers investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by Fedenia Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by Fedenia Advisers

Quarter filed Position value Share count Share price at filing
2026-06-30 $314k 40k 7.85

More positions owned by Fedenia Advisers

Invesco Qqq Trust Series I Etf (QQQ)
State Street Spdr S&p 500 Etf Etf (SPY)
Ishares National Muni Bond Etf Etf (MUB)
Sandisk Corp Stock (SNDK)
Vanguard S&p 500 Etf Etf (VOO)
Micron Technology Stock (MU)
Ishares Core Total Usd Bond Market Etf Etf (IUSB)
Western Digital Corp Stock (WDC)
Advanced Micro Devices Stock (AMD)
Seagate Technology Hldngs Plc Ord Stock (STX)
Lam Research Corp Stock (LRCX)
Marvell Technology Stock (MRVL)
Applied Matls Stock (AMAT)
Palo Alto Networks Stock (PANW)
Ishares Long-term National Muni Bond Etf Etf (LMUB)

View all positions for Fedenia Advisers

Top funds holding Abcellera Biologics

Baker Bros. Advisors
Capital World Investors
Two Sigma Investments
TD Waterhouse Canada
Bank of America Corporation
Ubs Global Asset Management Americas
Arrowpoint Asset Management
BlackRock
Susquehanna International
Driehaus Capital Management
Citadel Advisors
Morgan Stanley
UBS Group
Tudor Investment Corporation
Marshall Wace

View all funds holding Abcellera Biologics